Evidence map›Paper›PMID 28993780›Full record

ArticleFrontiers in immunology2017

Spontaneous Secretion of the Citrullination Enzyme PAD2 and Cell Surface Exposure of PAD4 by Neutrophils.

Yebin Zhou, Bo Chen, Nanette Mittereder, Raghothama Chaerkady, Martin Strain, Ling-Ling An, Saifur Rahman, Wenting Ma, Choon Pei Low, Denice Chan and 10 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 77 papers.

0numbers the graph read from it
0cells of the map it votes in
77citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

77 citing papers in PubMed, 115 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Neutrophil diversity and function in health and disease.Signal transduction and targeted therapy · 2024
    Review
  18. Article
  19. Article
  20. Article

17 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 4 institutions in 2 countries.

Yebin ZhouDepartment of Respiratory, Inflammation, and Autoimmunity, MedImmune LLC, Gaithersburg, MD, United States.
Bo ChenDepartment of Respiratory, Inflammation, and Autoimmunity, MedImmune LLC, Gaithersburg, MD, United States.
Nanette MitterederDepartment of Respiratory, Inflammation, and Autoimmunity, MedImmune LLC, Gaithersburg, MD, United States.
Raghothama ChaerkadyAntibody Discovery and Protein Engineering, MedImmune LLC., Gaithersburg, MD, United States.
Martin StrainAntibody Discovery and Protein Engineering, MedImmune LTD., Cambridge, United Kingdom.
Ling-Ling AnDepartment of Respiratory, Inflammation, and Autoimmunity, MedImmune LLC, Gaithersburg, MD, United States.
Saifur RahmanDepartment of Respiratory, Inflammation, and Autoimmunity, MedImmune LLC, Gaithersburg, MD, United States.
Wenting MaDepartment of Respiratory, Inflammation, and Autoimmunity, MedImmune LLC, Gaithersburg, MD, United States.
Choon Pei LowAntibody Discovery and Protein Engineering, MedImmune LTD., Cambridge, United Kingdom.
Denice ChanAntibody Discovery and Protein Engineering, MedImmune LTD., Cambridge, United Kingdom.
Frances NealAntibody Discovery and Protein Engineering, MedImmune LTD., Cambridge, United Kingdom.
Clifton O BinghamDivision of Rheumatology, Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, MD, United States.
Kevon SampsonDivision of Rheumatology, Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, MD, United States.
Erika DarrahDivision of Rheumatology, Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, MD, United States.
Richard M SiegelImmunoregulation Section, Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIH, Bethesda, MD, United States.
Sarfaraz HasniOffice of the Clinical Director, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIH, Bethesda, MD, United States.
Felipe AndradeDivision of Rheumatology, Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, MD, United States.
Katherine A VousdenAntibody Discovery and Protein Engineering, MedImmune LTD., Cambridge, United Kingdom.
Tomas MustelinDepartment of Respiratory, Inflammation, and Autoimmunity, MedImmune LLC, Gaithersburg, MD, United States.
Gary P SimsDepartment of Respiratory, Inflammation, and Autoimmunity, MedImmune LLC, Gaithersburg, MD, United States.
Recombinant Antibody Technology (United Kingdom) · GBJohns Hopkins University · USNational Institute of Arthritis and Musculoskeletal and Skin Diseases · USJohns Hopkins Medicine · US

Funding

Clinical Support Services for the NIAMS Intramural Research ProgramZIDAR041180 · NIAMS · NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES · PI COLBERT, ROBERT · 2009 to 2025
$119.2M
TL1A and its receptor DR3 in normal and autoimmune T cell responsesZIAAR041174 · NIAMS · NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES · PI SIEGEL, RICHARD M · 2009 to 2019
$9.8M
TNF-receptors and programmed cell death in regulation of autoimmunityZIAAR041133 · NIAMS · NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES · PI SIEGEL, RICHARD M · 2009 to 2019
$9.3M
TNFR1 in the regulation of autoinflammatory diseasesZIAAR041175 · NIAMS · NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES · PI SIEGEL, RICHARD M · 2009 to 2019
$6.5M
Phenotype-Specific Immune Responses in the Systemic VasculitidesP30AR053503 · NIAMS · JOHNS HOPKINS UNIVERSITY · PI ROSEN, ANTONY · 2006 to 2015
$6.4M
NIAMS NIH HHS P30 AR053503
6 · The paper itself

Abstract

Autoantibodies directed against citrullinated epitopes of proteins are highly diagnostic of rheumatoid arthritis (RA), and elevated levels of protein citrullination can be found in the joints of patients with RA. Calcium-dependent peptidyl-arginine deiminases (PAD) are the enzymes responsible for citrullination. PAD2 and PAD4 are enriched in neutrophils and likely drive citrullination under inflammatory conditions. PADs may be released during NETosis or cell death, but the mechanisms responsible for PAD activity under physiological conditions have not been fully elucidated. To understand how PADs citrullinate extracellular proteins, we investigated the cellular localization and activity of PAD2 and PAD4, and we report that viable neutrophils from healthy donors have active PAD4 exposed on their surface and spontaneously secrete PAD2. Neutrophil activation by some stimulatory agents increased the levels of immunoreactive PAD4 on the cell surface, and some stimuli reduced PAD2 secretion. Our data indicate that live neutrophils have the inherent capacity to express active extracellular PADs. These novel pathways are distinguished from intracellular PAD activation during NETosis and calcium influx-mediated hypercitrullination. Our study implies that extracellular PADs may have a physiological role under non-pathogenic conditions as well as a pathological role in RA.

Indexed as

citrullinationneutrophilPAD2PAD4rheumatoid arthritis

Identifiers

PMID28993780
PMCPMC5622307
OpenAlexW2759451658

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.